Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Eliem Therapeutics (ELYM)
NASDAQ:ELYM
RESEARCH TOOLSreports
Eliem Therapeutics (ELYM) Ownership - Who Owns Eliem Therapeutics?
35 Followers
Eliem Therapeutics (ELYM) Ownership Overview
16.28% Insiders
0.64% Mutual Funds
25.29% Other Institutional Investors
57.79% Public Companies and
Individual Investors
The ownership structure of Eliem Therapeutics (ELYM) stock is a mix of institutional, retail and individual investors. Approximately 25.93% of the company’s stock is owned by Institutional Investors, 16.28% is owned by Insiders and 57.79% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jul 19, 2024 | Valerie Morisset Evp, R&d And Cso | xxxxxxxxxxxxx | $289492 |
| Jul 17, 2024 | Valerie Morisset Evp, R&d And Cso | xxxxxxxxxxxxx | $356500 |
| Jul 16, 2024 | Valerie Morisset Evp, R&d And Cso | xxxxxxxxxxxxx | $650563 |
| Jul 11, 2024 | Valerie Morisset Evp, R&d And Cso | xxxxxxxxxxxxx | $736500 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 13,150,849 | Institution | 19.69% | 96,001,198 | |
| 811,680 | Institution | 1.22% | 5,925,264 | |
| 316,909 | Institution | 0.47% | 2,313,436 | |
| 308,817 | Institution | 0.46% | 2,254,364 | |
| 252,155 | Institution | 0.38% | 1,840,732 | |
| 61,246 | Institution | 0.09% | 447,096 | |
| 53,323 | Institution | 0.08% | 389,258 | |
| 9,374 | Institution | 0.01% | 68,430 | |
| 7,521 | Institution | 0.01% | 54,903 | |
| 3,519 | Institution | <0.01% | 25,689 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 308,817 | Institution | 0.46% | 2,254,364 | |
| 61,246 | Institution | 0.09% | 447,096 | |
| 53,323 | Institution | 0.08% | 389,258 | |
| 1,669 | Institution | <0.01% | 12,184 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 165,348 | Institution | 0.25% | 1,175,624 | |
| 158,636 | Institution | 0.24% | 1,158,043 | |
| 119,083 | Institution | 0.18% | 846,680 | |
| 77,124 | Institution | 0.12% | 563,005 | |
| 27,118 | Institution | 0.04% | 192,809 | |
| 16,395 | Institution | 0.02% | 119,684 | |
| 9,374 | Institution | 0.01% | 63,462 | |
| 5,648 | Institution | <0.01% | 38,237 | |
| 4,603 | Institution | <0.01% | 32,727 | |
| 3,519 | Institution | <0.01% | 23,824 |
FAQ
Who Owns Eliem Therapeutics (ELYM)?
According to the latest TipRanks data, approximately 25.29% of the company's stock is held by institutional investors, 16.28% is held by insiders, and 57.79% is held by retail investors.
What percentage of Eliem Therapeutics (ELYM) stock is held by institutional investors?
According to the latest TipRanks data, approximately 25.29% of Eliem Therapeutics (ELYM) stock is held by institutional investors.
What percentage of Eliem Therapeutics (ELYM) stock is held by retail investors?
According to the latest TipRanks data, approximately 57.79% of Eliem Therapeutics (ELYM) stock is held by retail investors.
Who owns the most shares of Eliem Therapeutics (ELYM)?
Peter Kolchinsky owns the most shares of Eliem Therapeutics (ELYM).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.